Taber MT[au] - Search Results

Year	Number of Results
1993	1
1994	1
1995	2
1996	2
1997	3
1998	1
2000	2
2001	2
2002	1
2003	1
2004	1
2005	5
2007	2
2009	1
2010	3
2013	2
2015	1
2016	1
2024	0

1

The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?

Kinney GG, Taber MT, Gribkoff VK. Kinney GG, et al. Among authors: taber mt. Mol Neurobiol. 2000 Jun;21(3):137-52. doi: 10.1385/mn:21:3:137. Mol Neurobiol. 2000. PMID: 11379796 Review.

2

Synthesis and SAR exploration of dinapsoline analogues.

Sit SY, Xie K, Jacutin-Porte S, Boy KM, Seanz J, Taber MT, Gulwadi AG, Korpinen CD, Burris KD, Molski TF, Ryan E, Xu C, Verdoorn T, Johnson G, Nichols DE, Mailman RB. Sit SY, et al. Among authors: taber mt. Bioorg Med Chem. 2004 Feb 15;12(4):715-34. doi: 10.1016/j.bmc.2003.11.015. Bioorg Med Chem. 2004. PMID: 14759732

3

Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area.

Taber MT, Das S, Fibiger HC. Taber MT, et al. J Neurochem. 1995 Sep;65(3):1407-10. doi: 10.1046/j.1471-4159.1995.65031407.x. J Neurochem. 1995. PMID: 7643120

4

Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.

King HD, Meng Z, Deskus JA, Sloan CP, Gao Q, Beno BR, Kozlowski ES, Lapaglia MA, Mattson GK, Molski TF, Taber MT, Lodge NJ, Mattson RJ, Macor JE. King HD, et al. Among authors: taber mt. J Med Chem. 2010 Nov 11;53(21):7564-72. doi: 10.1021/jm100515z. J Med Chem. 2010. PMID: 20949929

5

Activation of the mesocortical dopamine system by feeding: lack of a selective response to stress.

Taber MT, Fibiger HC. Taber MT, et al. Neuroscience. 1997 Mar;77(2):295-8. doi: 10.1016/s0306-4522(96)00529-5. Neuroscience. 1997. PMID: 9472391

6

Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.

Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, Johnson G, Krishnan BS, Kinney GG, Lombardo LA, Meanwell NA, Molinoff PB, Myers RA, Moon SL, Ortiz A, Pajor L, Pieschl RL, Post-Munson DJ, Signor LJ, Srinivas N, Taber MT, Thalody G, Trojnacki JT, Wiener H, Yeleswaram K, Yeola SW. Gribkoff VK, et al. Among authors: taber mt. Nat Med. 2001 Apr;7(4):471-7. doi: 10.1038/86546. Nat Med. 2001. PMID: 11283675

7

Synthesis, structure-activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonists.

Han X, Michne JA, Pin SS, Burris KD, Balanda LA, Fung LK, Fiedler T, Browman KE, Taber MT, Zhang J, Dubowchik GM. Han X, et al. Among authors: taber mt. Bioorg Med Chem Lett. 2005 Sep 1;15(17):3870-3. doi: 10.1016/j.bmcl.2005.05.117. Bioorg Med Chem Lett. 2005. PMID: 15990298

8

Discovery of Indazoles as Potent, Orally Active Dual Neurokinin 1 Receptor Antagonists and Serotonin Transporter Inhibitors for the Treatment of Depression.

Degnan AP, Tora GO, Huang H, Conlon DA, Davis CD, Hanumegowda UM, Hou X, Hsiao Y, Hu J, Krause R, Li YW, Newton AE, Pieschl RL, Raybon J, Rosner T, Sun JH, Taber MT, Taylor SJ, Wong MK, Zhang H, Lodge NJ, Bronson JJ, Macor JE, Gillman KW. Degnan AP, et al. Among authors: taber mt. ACS Chem Neurosci. 2016 Dec 21;7(12):1635-1640. doi: 10.1021/acschemneuro.6b00337. Epub 2016 Oct 18. ACS Chem Neurosci. 2016. PMID: 27744678

9

Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.

Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ. Mattson RJ, et al. Among authors: taber mt. J Med Chem. 2005 Sep 22;48(19):6023-34. doi: 10.1021/jm0503291. J Med Chem. 2005. PMID: 16162005

10

NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test.

Lelas S, Li YW, Wallace-Boone TL, Taber MT, Newton AE, Pieschl RL, Davis CD, Molski TF, Newberry KS, Parker MF, Gillman KW, Bronson JJ, Macor JE, Lodge NJ. Lelas S, et al. Among authors: taber mt. Neuropharmacology. 2013 Oct;73:232-40. doi: 10.1016/j.neuropharm.2013.05.038. Epub 2013 Jun 12. Neuropharmacology. 2013. PMID: 23770339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year